Detalles de la búsqueda
1.
Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer.
Molecules
; 28(17)2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37687169
2.
Design, synthesis, and biological evaluation of novel HDAC/CD13 dual inhibitors for the treatment of cancer.
Eur J Med Chem
; 260: 115752, 2023 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37647727
3.
Discovery of Novel 2,3-Dihydro-1H-indene-5-sulfonamide NLRP3 Inflammasome Inhibitors Targeting Colon as a Potential Therapy for Colitis.
J Med Chem
; 66(23): 16141-16167, 2023 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38029358
4.
Potent Hydrazide-Based HDAC Inhibitors with a Superior Pharmacokinetic Profile for Efficient Treatment of Acute Myeloid Leukemia In Vivo.
J Med Chem
; 65(1): 285-302, 2022 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34942071
5.
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity.
J Med Chem
; 63(10): 5501-5525, 2020 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32321249
Resultados
1 -
5
de 5
1
Próxima >
>>